The current status and future prospects of treatment for multiple myeloma.
D058186:Acute Kidney Injury / Q000150:complications / Q000188:drug therapy; D006585:Altretamine / Q000627:therapeutic use; D000740:Anemia / Q000150:complications / Q000188:drug therapy; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006934:Hypercalcemia / Q000150:complications / Q000188:drug therapy; D007372:Interferons / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy; D008558:Melphalan / Q000627:therapeutic use; D008577:Meningeal Neoplasms / Q000150:complications; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D013117:Spinal Cord Compression / Q000150:complications; D014747:Vinblastine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use; D014751:Vindesine
D014750:Vincristine; D014747:Vinblastine; D004317:Doxorubicin; D003520:Cyclophosphamide; D007372:Interferons; D008558:Melphalan; D006585:Altretamine; D014751:Vindesine